06.02.22
Guardion Health Sciences, a clinical nutrition company specializing in medical foods and nutraceuticals, has announced an agreement with OmegaQuant to provide Guardion with analytic testing and laboratory support services for current and future products.
OmegaQuant is an independent, CLIA-certified laboratory located in Sioux Falls, South Dakota, that offers an extensive suite of clinical tests to researchers, clinicians, and the public, including the Omega-3 Index, vitamin D, prenatal DHA, and mother’s milk DHA testing.
OmegaQuant performs fatty acid analysis for commercial and academic research collaborators and for consumers interested in monitoring their nutritional status in both blood and breast milk. The Omega-3 Index tests measure all the fatty acids in the blood, and reports levels of all 24 fatty acids, as well as the Omega-3 index, Ratios, and the Trans Fat Index.
“This relationship with OmegaQuant positions us to conduct a variety of research projects around both our current product lines, as well as to evaluate future products for efficacy,” said Bret Scholtes, Guardion’s CEO. “While we are still in the early stages of the relationship, we anticipate applying the Omega-3 Index test to advance the science of our current products, including the recently launched Omega Boost 1,200 mg Omega-3 Gel Bites recently launched under the Guardion flagship Viactiv brand.”
“We look forward to launching research projects with Guardion as we have with several top institutions such as Harvard University and the NIH, as well as with multiple healthcare businesses,” said Jason Polreis, OmegaQuant’s CEO. “Our proprietary standardized and validated testing helps organizations and individuals through their doctors better understand blood chemistry and the impact that fatty acid composition may have on overall health.”
OmegaQuant is an independent, CLIA-certified laboratory located in Sioux Falls, South Dakota, that offers an extensive suite of clinical tests to researchers, clinicians, and the public, including the Omega-3 Index, vitamin D, prenatal DHA, and mother’s milk DHA testing.
OmegaQuant performs fatty acid analysis for commercial and academic research collaborators and for consumers interested in monitoring their nutritional status in both blood and breast milk. The Omega-3 Index tests measure all the fatty acids in the blood, and reports levels of all 24 fatty acids, as well as the Omega-3 index, Ratios, and the Trans Fat Index.
“This relationship with OmegaQuant positions us to conduct a variety of research projects around both our current product lines, as well as to evaluate future products for efficacy,” said Bret Scholtes, Guardion’s CEO. “While we are still in the early stages of the relationship, we anticipate applying the Omega-3 Index test to advance the science of our current products, including the recently launched Omega Boost 1,200 mg Omega-3 Gel Bites recently launched under the Guardion flagship Viactiv brand.”
“We look forward to launching research projects with Guardion as we have with several top institutions such as Harvard University and the NIH, as well as with multiple healthcare businesses,” said Jason Polreis, OmegaQuant’s CEO. “Our proprietary standardized and validated testing helps organizations and individuals through their doctors better understand blood chemistry and the impact that fatty acid composition may have on overall health.”